Shell Asset Management’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,775
| Closed | -$55K | – | 1306 |
|
|
2022
Q4 | $55K | Sell |
6,775
-870
| -11% | -$7.06K | ﹤0.01% | 1253 |
|
|
2022
Q3 | $44K | Sell |
7,645
-1,048
| -12% | -$6.03K | ﹤0.01% | 1344 |
|
|
2022
Q2 | $38K | Buy |
8,693
+182
| +2% | +$796 | ﹤0.01% | 1373 |
|
|
2022
Q1 | $77K | Sell |
8,511
-1,223
| -13% | -$11.1K | ﹤0.01% | 1320 |
|
|
2021
Q4 | $199K | Buy |
9,734
+39
| +0.4% | +$797 | ﹤0.01% | 1213 |
|
|
2021
Q3 | $248K | Sell |
9,695
-470
| -5% | -$12K | 0.01% | 1140 |
|
|
2021
Q2 | $355K | Buy |
+10,165
| New | +$355K | 0.01% | 1061 |
|